CeleCor Therapeutics is Drug Discovery in United States that focus on molecule inhibitor business. Founded in 2017. They cover business area such as developer, contact treatment, segment, myocardial infarction, (STEMI, thrombolytic agent, percutaneous coronary intervention, auto-injector, decrease mortality, later development, heart failure.
2017
( 7 years old in 2024 )
Molecule Inhibitor
-
1155 Camino Del Mar
Suite 481
Del Mar, CA 92014
United States
Private
developercontact treatmentsegmentmyocardial infarction(STEMIthrombolytic agentpercutaneous coronary interventionauto-injectordecrease mortalitylater developmentheart failure
* We use standard office opening hours in near CeleCor Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
CeleCor Therapeutics is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), CeleCor Therapeutics business is focusing on Molecule Inhibitor.
CeleCor Therapeutics headquarter office and corporate office address is located in 1155 Camino Del Mar Suite 481 Del Mar, CA 92014 United States.
CeleCor Therapeutics was founded in United States.
In 2024, CeleCor Therapeutics is currently focus on molecule inhibitor sector.
Above is snippet of Google Trends for "molecule inhibitor" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with CeleCor Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
